While it exhibited low expression in normal urothelial bladder samples, around 34% of high-grade bladder cancer samples showed high levels of IGF2BP3 protein (Fig. 1S), consistent with the mRNA data. The gene discussed is IGF2BP3; the disease is urinary bladder carcinoma.